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Green Tea Extract and ()-Epigallocatechin-3-Gallate
Inhibit Mast Cell-Stimulated Type I Collagen
Expression in Keloid Fibroblasts via Blocking
PI-3K/Akt Signaling Pathways
Qunzhou Zhang1, A. Paul Kelly2, Lina Wang3, Samuel W. French4, Xudong Tang1, Hai S. Duong1,
Diana V. Messadi5 and Anh D. Le1,6
Keloid, a chronic fibro-proliferative disease, exhibits distinctive histological features characterized by
an abundant extracellular matrix stroma, a local infiltration of inflammatory cells including mast cells (MCs),
and a milieu of enriched cytokines. Previous studies have demonstrated that co-culture with MCs stimulate type
I collagen synthesis in fibroblasts, but the signaling mechanisms remain largely unknown. In this study, we
investigated the signaling pathways involved in MC-stimulated type I collagen synthesis and the effects of green
tea extract (GTE) and its major catechin, ()-epigallocatechin-3-gallate (EGCG), on collagen homeostasis in
keloid fibroblasts. Our results showed that MCs significantly stimulated type I collagen expression in keloid
fibroblasts, and the upregulation of type I collagen was significantly attenuated by blockade of phospha-
tidylinositol-3-kinase (PI-3K), mammalian target of rapamycin (mTOR), and p38 MAPK signaling pathways, but
not by blockade of ERK1/2 pathway. Furthermore, GTE and EGCG dramatically inhibited type I collagen
production possibly by interfering with the PI-3K/Akt/mTOR signaling pathway. Our findings suggest that
interaction between MCs and keloid fibroblasts may contribute to excessive collagen accumulation in keloids
and imply a therapeutic potential of green tea for the intervention and prevention of keloids and other fibrotic
diseases.
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INTRODUCTION
Keloids are fibrous overgrowth induced by cutaneous injury
(Tuan and Nichter, 1998; Niessen et al., 1999). Clinically,
keloids behave like benign dermal fibro-proliferative tumors
as they continue to grow and extend beyond the confines of
the original wound margins, without evidence of sponta-
neous regression as observed in hypertrophic scars (Ehrlich
et al., 1994). Histologically, keloids and hypertrophic scars
differ from normal skin and normal scars by their rich
vasculature (Rockwell et al., 1989; Lee et al., 2004), a high
density of mesenchymal cells, a thickened epidermal cell
layer, an increased infiltration of inflammatory cells including
lymphocytes, mast cells (MCs), and macrophages (Amadeu
et al., 2003), and an abundant deposition of extracellular
matrix (ECM) (Niessen et al., 1999).
Human type I collagen, the major component of ECM in
skin, bone, and ligament, comprises of two a1 (I) chains and
one a2 (I) chain, which are derived from pro-COL1A1 and
pro-COL1A2 genes, respectively (Ghosh, 2002). Abnormality in
collagen synthesis leading to an imbalance in ECM metabolism
has been recognized as an essential factor in the pathogenesis
of several fibrotic diseases including keloids (Niessen et al.,
1999; Myllyharju and Kivirikko, 2001). However, the mole-
cular mechanisms underlying the overproduction of type I
collagen in keloids still remain largely unknown.
MCs are tissue dwelling cells containing prominent
cytoplasmic granules. MC hyperplasia and activation have
been implicated in the pathogenesis of several chronic
inflammatory fibrotic diseases such as aberrant wound
healing, idiopathic lung fibrosis, scleroderma, liver fibrosis,
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inflammatory bowel diseases such as Crohn’s disease, and
rheumatoid arthritis (Benoist and Mathis, 2002; Puxeddu
et al., 2003; Nigrovic and Lee, 2005). Previous studies
have shown that MCs undergo significant qualitative and
quantitative changes during abnormal wound healing, which
may correlate with a prolonged inflammatory state, an
increase in fibroblast proliferation, and an aberrant collagen
production (Artuc et al., 1999; Huttunen et al., 2000; Abe
et al., 2002). Such changes in MCs have also been observed
in keloids and hypertrophic scars, thus implicating an
important role of MCs and their mediators in keloid formation
(Craig et al., 1986; Smith et al., 1987; Lee and Vijayasingam,
1995).
Green tea, derived from dried leaves of the plant Camelia
sinensis, harbors several polyphenolic components known
as catechins, including ()-epigallocatechin-3-gallate
(EGCG), ()-epigallocatechin, ()-epicatechin gallate, and
()-epicatechin. A wide range of pharmacological effects of
green tea and its major catechins has been reported with
promising therapeutic potentials in cancer, cardiovascular,
and neurological diseases (Shimizu and Weinstein, 2005;
Zaveri, 2006). In addition, several recent studies have
shown that polyphenols from green tea significantly
improved the quality of wound healing and scar formation
in a rat model (Kapoor et al., 2004), remarkably suppressed
both collagen production and collagenase activity in hepatic
stellate cells (Nakamuta et al., 2005), and dramatically
attenuated experimental cholestasis-induced liver fibrosis in
rats (Zhong et al., 2003). In this study, we explored whether
GTE and EGCG had any effect on type I collagen synthesis
in keloid fibroblasts co-cultured with human MCs. We
reported for the first time that both GTE and EGCG
significantly suppressed MC-stimulated type I collagen
expression in keloid fibroblasts. Our results also indicated
that the inhibitory effects of GTE and EGCG on type I
collagen expression in keloid fibroblasts appeared to be
mediated via the phosphatidylinositol-3-kinase (PI-3K)/Akt/
mTOR signaling pathways. These unique findings provided
further understanding of the molecular mechanisms under-
lying the antifibrogenic effects of GTE and EGCG, and
helped to further delineate the targets of therapeutic
intervention and prevention of keloids and other fibrotic
diseases.
RESULTS
MCs stimulate type I collagen expression in keloid
fibroblasts in vitro
To investigate the effects of MCs on type I collagen
expression in keloid fibroblasts, a fixed density of normal
skin or keloid fibroblasts was co-cultured with different
numbers of HMC-1 cells (a human leukemic mast cell
line) under the condition where direct cell–cell contact is
allowed. Our results showed that co-culture with HMC-1
cells led to a substantial increase in type I collagen synthesis
in both normal and keloid fibroblasts, and such increase was
dependent on the number of HMC-1 cells (Figure 1a and b).
Similar results were obtained by immunofluorescence studies
(Figure 1c).
MCs stimulate type I collagen expression in keloid fibroblasts
through activation PI-3K/Akt and p38 MAPK signaling pathways
Most recently, we have demonstrated that co-culture of
keloid fibroblasts and HMC-1 cells under the condition of
direct cell–cell contact led to the activation of both ERK1/2
and PI-3K/Akt signaling pathways (Zhang et al., 2006).
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Figure 1. HMC-1 cells stimulated type I collagen expression in fibroblasts
derived from keloids and their corresponding peripheral normal skins.
(a) Keloid fibroblasts (KF) or normal skin fibroblasts (NSK) (1105/well) were
directly co-cultured with increasing number of HMC-1 cells in a six-well plate
under normal culturing condition for 24 hours. Equal amount of cell lysates
(100mg) was subjected to Western blot analysis with a specific antibody
against type I collagen (Col-I). (b) Densitometric analysis of the results of (a).
The relative density ratio of the two bands of type I collagen to b-actin in
fibroblasts (FB) cultured alone was arbitrarily set as 1.0. (c) Dual-color
immunofluorescent staining of type I collagen (Green) in keloid fibroblasts
and c-kit on MCs (Red). Co-cultured cells (cell density ratio of 1:1) were
fixed in cold methanol:acetone (1/1) and stained with mouse monoclonal
antitype I collagen antibody and rabbit polyclonal anti-c-kit antibody
followed by Alexa Fluors568 conjugated goat anti-rabbit IgG and Alexa
Fluors488 conjugated goat anti-mouse IgG. Representative results from three
independent experiments are shown. Bar: 200 mM.
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Consistently, herein we demonstrated a time-dependent
increase in both phosphorylated ERK1/2 and Akt levels in
the co-cultured keloid fibroblasts and HMC-1 cells under
normal conditions, with maximal activity at 1–2 hours
(Figure 2). Likewise, we also observed a time-dependent
increase in the phosphorylated levels of p38 MAPK,
eukaryotic initiation factors (eIFs) binding protein (p-4E-BP)-
1 and p70S6K1 in the co-culture (Figure 2), implying the
involvement of several important signaling pathways.
Next, we ask whether these activated signaling pathways
are involved in MC-induced upregulation of type I collagen
expression. Keloid fibroblasts at about 80% confluence were
pretreated with different concentrations of various protein
kinase inhibitors for 1 hour followed by co-culture with the
same cell density of HMC-1 cells for 24 hours under normal
culturing conditions. Cell viability of both fibroblasts and
HMC-1 cells was more than 95% at all concentrations tested
as determined by trypan blue exclusion (data not shown).
Our results showed that pretreatment of keloid fibroblasts
with LY294002, a specific inhibitor of PI-3K, dramatically
decreased HMC-1-stimulated type collagen expression in a
dose-dependent manner (Po0.05) (Figure 3a and b). Similar
findings were obtained with wortmannin, an alternative and
structurally different inhibitor of PI-3K (Po0.05) (Figure 3c
and d). Meanwhile, pretreatment of keloid fibroblasts with
different concentrations of rapamycin, a specific inhibitor of
mammalian target of rapamycin (mTOR), or SB203580, a
specific inhibitor of p38 MAPK, also led to a dose-dependent
inhibition of type-I collagen expression stimulated by HMC-1
cells (Po0.05) (Figure 3c–f). However, blocking ERK1/2
signaling pathway by pretreatment of keloid fibroblasts with
PD98059 or U0126 had no obvious inhibitory effects on
HMC-1-stimulated type I collagen expression (P40.05)
(Figure 3a, e, and f). To rule out the possibility that the
suppression of MCs stimulated type I collagen synthesis was
secondary to drug toxicity, keloid fibroblasts were exposed to
LY294002, rapamycin, or SB203580 at maximal concentra-
tions for 24 hours in the absence of MCs. The results indicated
that mere exposure to these inhibitors had no obvious effects
on type I collagen levels in keloid fibroblasts in the absence
of HMC-1 cells (Figure S1). Taken together, these observa-
tions indicated that both PI-3K/Akt/mTOR and p38 MAPK
signaling pathways are involved in MC-stimulated upregula-
tion of type I collagen expression in keloid fibroblasts.
GTE and EGCG suppressed HMC-1-stimulated type I collagen
expression in keloid fibroblasts by interfering with PI-3K/Ak
signaling pathway
Previous studies have shown that green tea and its major
catechins not only have inhibitory effects on MC activation
(Li et al., 2005), but also possess antifibrogenic activity in
some animal models (Nakamuta et al., 2005). To explore
whether green tea extract (GTE) and ()-epigallocatechin-3-
gallate (EGCG) had any effects on MC-stimulated type I
collagen expression, keloid fibroblasts were pretreated with
different concentrations of GTE or EGCG for 1 hour followed
by co-culture with the same cell density of HMC-1 cells for
additional 24 hours under normal culturing conditions. Our
results showed that pretreatment with GTE or EGCG led to a
dose-dependent reduction in HMC-1-stimulated type I
collagen protein production in keloid fibroblasts (Po0.05)
(Figure 4a and b). Immunofluorescence studies also illu-
strated that treatment with GTE significantly attenuated type I
collagen signals in keloid fibroblasts stimulated by HMC-1
cells (Figure 4c, the right panel vs the middle panel). To rule
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Figure 2. Activation of multiple signaling pathways in the co-cultured keloid
fibroblasts and HMC-1 cells. Keloid fibroblasts were directly co-cultured with
the same density of HMC-1 cells for different time intervals, and equal
amounts of cell lysates were subjected to Western blot analysis with various
specific antibodies. Representative results from three independent
experiments are shown.
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Figure 3. Involvement of PI-3k/Akt/mTOR and p38 MAPK pathways in
MC-stimulated type I collagen production in keloid fibroblasts. (a, c, and e)
Keloid fibroblasts (KF) were pretreated with different concentrations of various
inhibitors followed by direct co-culture with the same density of
HMC-1 cells under normal culturing condition for 24 hours. Equal amounts
of cell lysates (100 mg) were subjected to Western blot analysis with specific
antibody against type I collagen (Col-I). (b, d, and f) Densitometric
analysis of results from (a, c, and e), respectively. The relative density ratio
of the two bands of type I collagen (Col-I) to b-actin in keloid fibroblast (KF)
cultured alone was arbitrarily set as 1.0. The results represent three
independent experiments and expressed as the mean7SD.
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out the possibility that the inhibitory effect of GTE and EGCG
on type I collagen expression was due to cellular toxicity,
MTT assay was performed to determine the cell viability
following treatment with different concentrations of GTE and
EGCG under normal conditions for 24 hours. No obvious
changes in cell viability were observed in both keloid
fibroblasts and HMC-1 cells (Figure 4d).
Next, we explored the signaling mechanisms underlying
the inhibitory effects of GTE and EGCG on HMC-1-stimulated
type I collagen expression in keloid fibroblasts. As expected,
pretreatment of keloid fibroblasts with PD98059 (50 mM) and
SB203580 (10 mM) significantly inhibited the activation of
ERK1/2 and p38 MAPK, respectively (Po0.05; Figure 5a
and b). However, exposure of keloid fibroblasts to GTE or
EGCG only led to a moderate decrease in the phosphorylated
ERK1/2 levels, but had no obvious inhibitory effects on the
activation of p38 MAPK (P40.05, Figure 5a–d). On the other
hand, similar to the inhibitory effects of LY294002, treatment
with GTE or EGCG resulted in a dose-dependent reduction in
the increased levels of phosphorylated Akt, 4E-BP, and
p70S6K in the co-cultured keloid fibroblasts and HMC-1
cells (Figure 5e), which paralleled their inhibitory effects on
HMC-1-stimulated upregulation of type I collagen expression
(Figure 4). To rule out drug toxicity, keloid fibroblasts were
exposed to increased concentrations of LY294002, PD98059,
and SB203580 for 1 hour. Our results showed no obvious
changes in the levels of these phosphorylated signaling
components (Figure S2). Collectively, these data suggest that
GTE and EGCG inhibited MC-stimulated type I collagen
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Figure 4. GTE and EGCG inhibited MC-stimulated type I collagen
production in keloid fibroblasts. (a) Keloid fibroblasts (KF) were pretreated
with different concentrations of GTE or EGCG for 1 hour followed by
direct co-culture with the same number of HMC-1 cells under normal
culturing condition for 24 hours. Equal amounts of cell lysates (100 mg)
were subjected to Western blot analysis with specific antibody against type I
collagen. (b) Densitometric analysis of results from (a). The relative density
ratio of the two bands of type I collagen (Col-I) to b-actin in KF cultured alone
was arbitrarily set as 1.0. (c) Dual-color immunofluorescent staining of type I
collagen (Green) in KF and c-kit on HMC-1 cells (Red). Keloid fibroblasts
(KF) were pretreated with 80 mg/ml GTE for 1 hour followed by co-cultured
with HMC-1 (cell density ratio of 1:1) for 16 hours. The co-cultured cells were
fixed in cold methanol:acetone (1:1) and stained with mouse monoclonal
antibody against type I collagen and rabbit polyclonal antibody against c-kit,
followed by Alexa Fluors568 conjugated goat anti-rabbit IgG and Alexa
Fluors488 conjugated goat anti-mouse IgG. (d) KF or HMC-1 ells were
treated with various concentrations of GTE or EGCG for 24 hours under
normal culturing conditions and cell viability was assayed using MTT method.
The percentage of viable cells represented the mean7SD from three replicate
experiments. The results represent three independent experiments and
expressed as the mean7SD. Bar: 200 mM.
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Figure 5. Effects of GTE and EGCG on the activation of signaling pathways
in the co-cultured keloid fibroblasts and HMC-1 cells. Keloid fibroblasts (KF)
were pretreated with different concentrations of GTE or EGCG, or various
kinase inhibitors for 1 hour, followed by direct co-culture with the same cell
number of HMC-1 cells under normal culturing condition for 1 hour. Equal
amounts of cell lysates were subjected to Western blot analysis with specific
antibody against the phosphorylated form of ERK1/2 (a), p38 MAPK (c), Akt,
p70S6K, and 4E-BP1 (e), respectively. (b and d) Densitometric analysis of
results from (a) and (c). The relative density ratio of the p-ERK1/2 or p-Akt to
total (T-) ERK1/2 or total (T-) Akt in KF cultured alone was arbitrarily set as 1.0.
Data presented are representative of results from three independent
experiments.
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expression in keloid fibroblasts mainly by interfering with the
PI-3K/Akt signaling pathways.
DISCUSSION
MCs have been attributed to several patho-physiological
conditions via their ability to respond to a composite range of
stimuli, and release of a wide array of biologically active
mediators (Mekori and Metcalfe, 2000; Ribatti et al., 2004;
Nigrovic and Lee, 2005). Several studies have shown that
co-culture with MCs promote type I collagen synthesis in
fibroblasts (Abe et al., 2000; Garbuzenko et al., 2002).
Consistently, our findings demonstrated that co-culture with
MCs substantially stimulated type I collagen synthesis in
keloid fibroblasts (Figure 1).
Most recently, our group has reported the activation of
ERK1/2 and PI-3K/Akt signaling pathways in the co-cultured
keloid fibroblasts and HMC-1 cells (Zhang et al., 2006). The
current study has extended our previous observation and
found that co-culture with HMC-1 cells activated not only
ERK1/2 and PI-3K/Akt signaling pathways but also p38 MAPK
pathway (Figure 2). This finding is consistent with previous
report that co-culture of MC and lung fibroblast with direct
cell–cell interaction led to the activation of p38 MAPKs
(Fitzgerald et al., 2004). In addition, our results also indicated
that co-culture with HMC-1 cells upregulated both phos-
phorylated 4E-BP and p70S6K (Figure 2), two important
regulatory components of protein translational machinery
that are downstream targets of PI-3K/Akt/mTOR signaling
pathways. The involvement of ERK1/2, PI-3K/Akt/mTOR, and
p38 MAPK signaling pathways have been described in the
upregulation of type I collagen expression in dermal
fibroblasts (Lim et al., 2003; Asano et al., 2004; Ihn et al.,
2005). In this study, we have demonstrated for the first time
that treatment with specific inhibitors of PI-3K, mTOR and
p38 MAPK significantly inhibited MC-stimulated type I
collagen production in keloid fibroblasts, while treatment
with specific inhibitors of ERK1/2 had no obvious inhibitory
effects (Figure 3). These findings suggest that MCs stimulate
type I collagen expression in keloid fibroblasts via activating
both PI-3K/Akt/mTOR and p38 MAPK signaling pathways.
GTE and its major polyphenolic components have long
been reported to possess various pharmacological activities
with a broad variety of health benefits (Yang et al., 2002).
Recent studies have shown that some components of green
tea can inhibit MC activation (Yamamoto et al., 1998; Li
et al., 2005), and affect ECM metabolism/remodeling in
several experimental models (Zhong et al., 2003; Kapoor
et al., 2004; Nakamuta et al., 2005). In this study, we
reported that GTE and EGCG had strong inhibitory effects on
MC-stimulated type I collagen production in keloid fibro-
blasts (Figure 4). Moreover, our results indicated that
treatment with GTE or EGCG suppressed the phosphorylated
levels of Akt, 4E-BP-1, p70S6K1, and ERK1/2, but had no
obvious inhibitory effects on p38 MAPK in the co-cultured
keloid fibroblasts and HMC-1 cells (Figure 5). These results
suggest that GTE or EGCG harbor potential antifibrogenic
activity by inhibiting MC-stimulated type I collagen produc-
tion mainly via the PI-3K/Akt/mTOR signaling pathways.
However, further studies are required to explore whether the
inhibitory effects of GTE and EGCG on MC-stimulated type I
collagen expression were due to their direct effects either on
the activation of MCs or keloid fibroblasts, or both.
In summary, the present study has demonstrated that MCs
can stimulate type I collagen production via activating
multiple signaling pathways in keloid fibroblasts. Keloids, a
chronic fibroproliferative disease, are characterized by
excessive collagen deposition, and, notoriously prone to
recurrence. Despite several treatment approaches, no single
modality has proven successful (Kelly, 2004; Burd and
Huang, 2005). Herein, we have demonstrated for the first
time that both GTE and EGCG significantly inhibited MC-
stimulated type I collagen expression by suppressing activa-
tion of the PI-3k/Akt/mTOR signaling pathways in keloid
fibroblasts. Our unique findings have provided further
understanding of the molecular mechanisms of keloid
pathogenesis and identify a therapeutic potential of green
tea for the intervention and prevention of keloids and other
fibrotic diseases.
MATERIALS AND METHODS
Reagents
GTE (Pharmanex Inc., Provo, UT) and EGCG (Sigma, St Louis, MO)
were dissolved in distilled water and stored at 801C as stock
solutions. The purity and components of GTE were previously
described (Lu et al., 2005). PD98059, LY294002, U0126, wortman-
nin, SB203580, and rapamycin were purchased from Calbiochem
(La Jolla, CA). All inhibitors were dissolved in DMSO. Cell viability
using trypan blue exclusion was determined for both keloid
fibroblasts and HMC-1 cells at the highest concentrations of
inhibitors used. Mouse monoclonal antibodies against human type
I collagen and b-actin were obtained from Sigma. Mouse mono-
clonal antibodies against human total or phosphorylated ERK1/2
(Thr202/Tyr204) or Akt (Ser473), p38 MAPK were from New England
Biolabs Inc. (Beverly, MA). Antibodies for phosphorylated Mr 70,000
ribosomal protein S6 kinase 1 (p70S6K) (Thr421/Ser424) and
eukaryotic initiation factor 4E (eIF)-binding protein 1 (4E-BP1)
(Ser65/Thr70) were from Santa Cruz Biotechnology (Santa Cruz,
CA). Rabbit polyclonal antibodies against human c-kit and type I
collagen were from OncogeneTM Research Products (San Diego, CA)
and Rockland Immunochemicals (Gilbertsville, PA), respectively.
Horseradish peroxidase conjugated secondary antibodies were from
PIERCE (Rockford, IL). Alexa Fluors568 conjugated rabbit anti-goat
IgG and Alexa Fluors488 conjugated goat anti-mouse IgG were
from Molecular Probes Inc. (Eugene, OR). All reagents used were
analytical grade.
Cell origin and cell culture
All studies have been approved by the Institutional Review Board of
the University of Southern California and were conducted with strict
adherence to the Declaration of Helsinki Principles. Primary cultures
of human dermal fibroblasts were isolated by enzymatic digestion of
keloid tissues obtained from patients at King Drew Medical Center
(Zhang et al., 2003). All keloidal tissues were from untreated,
primary lesions. Fibroblasts were maintained in DMEM (Gibco,
Rockville, MD) supplemented with 10% fetal bovine serum. Cells
from passage 2 through 8 were used for experiments and routinely
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monitored for cell proliferation, morphology, and phenotype. HMC-1,
a human MC leukemia cell line (a generous gift of Dr JH Butterfield,
Mayo Clinic, Rochester, MN), was cultured in Iscove’s medium
(Gibco) supplemented with 10% fetal bovine serum, antibiotics,
2 mmol/l L-glutamine, 1.2 mmol/l a-thioglycerol (Sigma, St Louis,
MO). All cultures were maintained at 371C, 5% CO2, and 20% O2.
Co-culture of HMC-1 and keloid fibroblasts
Keloid fibroblasts (1 105/well) were seeded on the bottom of a six-
well plate and maintained at normal culturing conditions (371C, 5%
CO2, and 20% O2) for at least 24 hours. Different densities of HMC-1
cells were seeded on top of the monolayer of fibroblasts and
co-cultured for different time intervals based on experimental
purposes. Fibroblasts at about 80% confluence were pretreated with
different concentrations of GTE, EGCG, or various kinase inhibitors
for 1 hour followed by co-culturing with the same cell density of
HMC-1 cells (cell density ratio of 1:1) under normal culturing
conditions for indicated time periods. Cell lysates were prepared for
Western blot analysis.
Western blot analyses
To determine type I collagen, and phosphorylated ERK1/2 and Akt
levels, cells were solubilized in lysis buffer (50 mM Tris-HCl, pH 7.5,
150 mM NaCl, 5 mM EDTA, 200mM Na3VO4, 50 mM NaF, 0.5%
Triton X-100) supplemented with 10 mM dithiothreitol, 200 mM
phenylmethylsulfonyl fluoride and protease inhibitor cocktails
(Sigma). Equal protein amounts of cell lysates were electrophoresed
on 7.5–10% SDS-polyacrylamide gels and electroblotted onto
nitrocellulose membranes (Hybond ECL, Amersham Pharmacia).
After blocking with TBS/5% skim milk, the membranes were
incubated with specific primary antibodies, followed by a horse-
radish peroxidase conjugated secondary antibodies (1:2,000)
(Pierce, Rockford, IL), and visualized using an enhanced chemilu-
minescent (ECL) detection.
Immunofluorescence studies
Keloid fibroblasts were seeded on four-well Lab-TeksII Chamber
SlideTM System (Nalge Nunc Int., Naperville, IL) (1 104) and
cultured for 24 hours under normal condition, followed by co-
culture with the same number of HMC-1 cells under the condition of
direct cell–cell contact. After incubation under normoxia for
24 hours, the medium was removed, and cells were fixed with cold
methanol:acetone (1:1) for 15 minutes. The fixed cells were washed,
and incubated at 41C overnight with a mouse monoclonal anti-
human type I collagen antibody (1:100) and a rabbit polyclonal anti-
human c-kit antibody (1:200). Cells were washed, incubated at room
temperature for 1 hour with Alexa Fluors568 conjugated goat anti-
rabbit IgG (1:2,000; 0.5 mg/ml), and Alexa Fluors488 conjugated
goat anti-mouse IgG (1:2,000; 0.5 mg/ml). Slides were then viewed
and photographed under a fluorescence microscope. Type I collagen
expression appeared green and c-kit-positive HMC-1 cells were
stained red. Cells incubated with fluoroscein-conjugated secondary
antibodies in the absence of primary antibodies were used as
negative control.
Statistical analysis
Data are presented as the mean7SD of duplicate experiments
carried out for at least three separate runs. One representative data
set from these three independent experiments is presented where
appropriate. Error bars represent SD. A paired Student’s test was
employed for statistical analysis, with significant differences
determined as Po0.05.
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SUPPLEMENTARY MATERIAL
Figure S1. Effects of protein kinase inhibitors on type I collagen expression in
keloid fibroblasts (KF) in the absence of HMC-1 cells.
Figure S2. Effects of protein kinase inhibitors on the activation of different
protein kinases in keloid fibroblasts (KF) in the absence of HMC-1 cells.
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